PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 2, 2024Cancer Research1 citations

Abstract PO1-05-04: CDK4/6 inhibitor-induced Interstitial Lung Disease (ILD) - A Case Series

View Full Paper
Ask AI
Bookmark
Share

Authors

ACAmi ChitaliaKSKrishna Shah

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chitalia et al. (2024) studied this question.

synapsesocial.com/papers/68e6bd3bb6db64358763d86ehttps://doi.org/10.1158/1538-7445.sabcs23-po1-05-04
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PS5-06-02: Cdk4/6 inhibitor-induced interstitial lung disease: a rare but severe complication in breast cancer treatment2026
  2. 2Palbociclib-Induced Interstitial Lung Disease in Metastatic Breast Cancer: A Case Report and Clinical Considerations2025
  3. 3A52-22 The Double-Edged Sword of CDK 4/6 Inhibition, Abemaciclib-induced Interstitial Lung Disease: From Subtle Opacity to Fulminant Respiratory Failure in Days2026
  4. 4Clinical features and management for CDK4/6 inhibitor-DILI.2026
  5. 5Abstract PO5-20-10: Treatment with CDK4/6 Inhibitor in a Patient with Metastatic Breast Cancer Causing Myelophthisis2024